XSculpt

XSculpt operates as a specialized medical practice in Chicago, Illinois, focusing on male body contouring and metabolic optimization under the direction of Marc A. Adajar, M.D., F.A.C.S., a board-certified surgeon with fellowship training in aesthetic and reconstructive procedures. The clinic addresses gynecomastia, hormonal imbalances affecting body composition, and medically supervised weight management through both surgical and pharmaceutical interventions. Dr. Adajar's dual approach combines surgical expertise in chest wall reconstruction with evidence-based peptide therapy protocols, allowing patients to address both structural and metabolic contributors to unwanted body composition changes.

The medical weight loss program at XSculpt centers on GLP-1 receptor agonist therapy using semaglutide and tirzepatide, both FDA-approved medications that regulate appetite signaling and glucose metabolism. Semaglutide works through single-hormone pathway activation, while tirzepatide engages dual incretin receptors (GIP and GLP-1) for enhanced metabolic effects. Dr. Adajar prescribes these peptides as part of comprehensive weight management protocols that include metabolic assessment, dosing titration based on individual response, and monitoring for body composition changes rather than scale weight alone. Patients typically begin with low-dose weekly injections that increase gradually over 16-20 weeks, with ongoing adjustments based on tolerance and progress toward body composition goals. The clinic's approach integrates these peptide therapies with hormone optimization strategies, particularly for men experiencing testosterone decline that compounds weight gain and gynecomastia development.

Dr. Adajar's surgical fellowship training informs his conservative approach to gynecomastia treatment, where he evaluates whether glandular tissue excess, adipose accumulation, or hormonal factors drive chest enlargement. For men with significant glandular components, surgical excision remains the definitive treatment, while those with primarily fatty deposits may achieve results through targeted weight loss with semaglutide or tirzepatide before considering surgery. The clinic's hormone optimization protocols address underlying endocrine contributors, including elevated estrogen-to-testosterone ratios, prolactin elevations, or medication-induced gynecomastia. This diagnostic framework prevents unnecessary surgical intervention when metabolic correction can resolve the condition, while identifying candidates who require combined surgical and medical management for optimal chest contour restoration.

Patients access XSculpt services through virtual consultations conducted for Illinois residents, where Dr. Adajar reviews medical history, current medications, laboratory values, and photographic documentation to develop individualized treatment plans. The telehealth model allows men throughout Illinois to consult with a board-certified surgeon specializing in male body composition issues without traveling to the Chicago office for initial evaluation. During virtual visits, Dr. Adajar discusses realistic expectations for peptide therapy timelines, typical response patterns to semaglutide versus tirzepatide, potential side effects including nausea and injection site reactions, and monitoring protocols that include periodic metabolic panels and body composition assessments. For surgical candidates, the virtual consultation establishes candidacy and treatment planning, with in-person evaluation scheduled when patients decide to proceed with gynecomastia correction or body contouring procedures.

XSculpt's integration of surgical expertise with peptide-based weight management distinguishes the practice from general weight loss clinics and cosmetic surgery centers that treat these concerns separately. Dr. Adajar's F.A.C.S. credential (Fellow of the American College of Surgeons) reflects advanced training and peer recognition in surgical practice, providing patients with access to a surgeon who understands both the technical aspects of body contouring and the metabolic factors that influence long-term results. The clinic's focus on male-specific body composition issues—particularly gynecomastia and hormone-related weight distribution—addresses a patient population often underserved by general aesthetic practices. Illinois residents seeking medical weight loss with semaglutide or tirzepatide, hormone optimization for body composition improvement, or surgical correction of gynecomastia can access Dr. Adajar's specialized expertise through the clinic's virtual consultation platform.